Physician

Faria Ali, MD

According to 2025 Medicare claims, Faria Ali, MD (NPI: 1225565666) practices hematology/oncology in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is COASTAL CANCER CENTER LLC (NPI: 1881614170; TIN: 570777346) and primary practice location at 29572-4128.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 635 traditional Medicare patients, billed 109,369 HCPCS/CPT codes, and received $2,170,668 in Medicare payments. The top billing code was 36415 (Insertion of needle into vein for collection of blood sample). Part D data shows 374 prescription claims across 90 beneficiaries totaling $595,823 in drug costs, led by Lenalidomide (Lenalidomide). Open Payments data shows 35 records totaling $922. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $14,628 to $595,823. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2023 Medicare payment: $216,487 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,170,668 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202317813,522$216,487
2024635109,369$2,170,668

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$406K$812K2017 Drug cost: $14,628 (USD; Tot_Drug_Cst)2018 Drug cost: $29,270 (USD; Tot_Drug_Cst)2019 Drug cost: $61,577 (USD; Tot_Drug_Cst)2020 Drug cost: $85,571 (USD; Tot_Drug_Cst)2021 Drug cost: $383,144 (USD; Tot_Drug_Cst)2022 Drug cost: $811,838 (USD; Tot_Drug_Cst)2023 Drug cost: $668,024 (USD; Tot_Drug_Cst)2024 Drug cost: $595,823 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201745174$14,628
201894497$29,270
2019123693$61,577
202082377$85,571
202151193$383,144
202252169$811,838
202348169$668,024
202490374$595,823

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
36415Insertion of needle into vein for collection of blood sample3431,118$9
80076Liver function blood test panel286857$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3391,080$8
82565Blood creatinine level285875$5
84100Phosphate level285856$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide13364$167,720
Prochlorperazine MaleateProchlorperazine Maleate20388$438
Ondansetron OdtOndansetron13355$422
HydroxyureaHydroxyurea16625$358
MirtazapineMirtazapine251,410$311

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$922Novocure Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Faria Ali, MD?

Tedicare shows public-source Medicare data for Faria Ali, MD (NPI 1225565666), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Faria Ali, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Faria Ali, MD?

Faria Ali, MD is linked to COASTAL CANCER CENTER LLC (billing NPI 1881614170) in the available physician profile data.

Does Faria Ali, MD have Open Payments data?

Faria Ali, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.